JP2019536783A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019536783A5 JP2019536783A5 JP2019528632A JP2019528632A JP2019536783A5 JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5 JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5
- Authority
- JP
- Japan
- Prior art keywords
- tyrosine
- methyl
- cancer
- composition according
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022122538A JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/365,120 US20170080093A1 (en) | 2013-10-22 | 2016-11-30 | Tyrosine Derivatives And Compositions Comprising Them |
| US15/365,120 | 2016-11-30 | ||
| PCT/US2017/063865 WO2018102506A1 (en) | 2016-11-30 | 2017-11-30 | Tyrosine derivatives and compositions comprising them |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122538A Division JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019536783A JP2019536783A (ja) | 2019-12-19 |
| JP2019536783A5 true JP2019536783A5 (https=) | 2021-01-14 |
Family
ID=60703174
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528632A Pending JP2019536783A (ja) | 2016-11-30 | 2017-11-30 | チロシン誘導体及びそれらを含む組成物 |
| JP2022122538A Withdrawn JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122538A Withdrawn JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3548086A1 (https=) |
| JP (2) | JP2019536783A (https=) |
| KR (1) | KR20190089191A (https=) |
| CN (1) | CN110062633A (https=) |
| AU (1) | AU2017368135A1 (https=) |
| BR (1) | BR112019011033A2 (https=) |
| CA (1) | CA3045110A1 (https=) |
| EA (1) | EA201991305A1 (https=) |
| IL (1) | IL266840A (https=) |
| MX (1) | MX2019006326A (https=) |
| PH (1) | PH12019501186A1 (https=) |
| WO (1) | WO2018102506A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111743887A (zh) * | 2019-03-26 | 2020-10-09 | 深圳先进技术研究院 | α-甲基酪氨酸或其衍生物的用途 |
| PH12021552866A1 (en) | 2019-05-14 | 2022-11-07 | Tyme Inc | Compositions and methods for treating cancer |
| CN115379851A (zh) * | 2019-11-07 | 2022-11-22 | 因斯瑞拜奥有限公司 | 使用生长因子抗体与非酪氨酸靶向激酶抑制剂的组合的方法和组合物 |
| WO2021146506A2 (en) * | 2020-01-17 | 2021-07-22 | Tyme, Inc. | Compositions and methods for modulating cancer |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| EP3075247B1 (en) * | 2004-02-02 | 2022-10-12 | BioSight Ltd. | Conjugates for cancer therapy and diagnosis |
| KR20090014164A (ko) * | 2006-04-19 | 2009-02-06 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 세포 영상화 및 치료를 위한 조성물 및 방법 |
| EP3050566B1 (en) * | 2007-09-10 | 2018-11-28 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
| PL2804599T3 (pl) * | 2012-01-17 | 2019-06-28 | Tyme, Inc. | Terapia skojarzona do leczenia nowotworu złośliwego |
| US9585841B2 (en) * | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
-
2017
- 2017-11-30 CA CA3045110A patent/CA3045110A1/en active Pending
- 2017-11-30 BR BR112019011033A patent/BR112019011033A2/pt not_active IP Right Cessation
- 2017-11-30 AU AU2017368135A patent/AU2017368135A1/en not_active Abandoned
- 2017-11-30 WO PCT/US2017/063865 patent/WO2018102506A1/en not_active Ceased
- 2017-11-30 CN CN201780074235.7A patent/CN110062633A/zh active Pending
- 2017-11-30 EP EP17817552.7A patent/EP3548086A1/en not_active Withdrawn
- 2017-11-30 KR KR1020197018473A patent/KR20190089191A/ko not_active Ceased
- 2017-11-30 JP JP2019528632A patent/JP2019536783A/ja active Pending
- 2017-11-30 MX MX2019006326A patent/MX2019006326A/es unknown
- 2017-11-30 EA EA201991305A patent/EA201991305A1/ru unknown
-
2019
- 2019-05-23 IL IL266840A patent/IL266840A/en unknown
- 2019-05-29 PH PH12019501186A patent/PH12019501186A1/en unknown
-
2022
- 2022-08-01 JP JP2022122538A patent/JP2022153587A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019536783A5 (https=) | ||
| JPWO2020130125A1 (ja) | 抗体−薬物コンジュゲートとキナーゼ阻害剤の組み合わせ | |
| JP2019504100A5 (https=) | ||
| JP2018533582A5 (https=) | ||
| RU2014152107A (ru) | Комбинированная терапия с использованием антител к клаудину 18.2 для лечения рака | |
| EP3423112A1 (en) | Hsp90 inhibitor drug conjugates | |
| JP2016514103A5 (ja) | 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体 | |
| JP2012505838A5 (https=) | ||
| JP2006265245A5 (https=) | ||
| JP2022551652A (ja) | 線維芽細胞増殖因子受容体シグナル伝達の調節不全を伴う癌の標的処置 | |
| RU2016127634A (ru) | Гетероциклические модуляторы синтеза липидов для применения против рака и вирусных инфекций | |
| JP2022153587A (ja) | チロシン誘導体及びそれらを含む組成物 | |
| JP2013528174A5 (https=) | ||
| US20220387544A1 (en) | Novel therapeutic use | |
| KR102896612B1 (ko) | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 | |
| CN101715342A (zh) | 钴胺素紫杉烷生物结合物 | |
| CN112043831A (zh) | 用于联合治疗乳腺癌的喹啉类化合物 | |
| WO2022047400A1 (en) | 5'-substituted nucleoside monophosphates, prodrugs thereof, and uses related thereto | |
| US11110105B2 (en) | Compounds, composition and uses thereof for treating cancer | |
| JPWO2020123991A5 (https=) | ||
| AU2013233094A1 (en) | Novel antitumor agent comprising combination of three agents | |
| JP2011514356A5 (https=) | ||
| JP2020535112A (ja) | Ｍｉｄｈ１阻害剤とｄｎａ低メチル化剤（ｈｍａ）との組合せ | |
| JP2009506019A (ja) | 癌治療のための組み合わせ | |
| CN103826645A (zh) | 砷在癌症治疗保护中的用途 |